Fidelity Small Cap Growth Fund Class Z (FIDGX)
This fund is designed to achieve long-term capital growth for investors. Its portfolio is primarily composed of common equity shares. A significant portion, at least 80%, of its assets are dedicated to companies characterized by small market capitalizations. The investment strategy focuses on selecting businesses that Fidelity Management & Research Company (FMR) believes exhibit strong potential for expansion, often termed "growth stocks." The fund diversifies its holdings across both domestic (U.S.) and international issuers. Investment decisions are made through a meticulous fundamental analysis, evaluating factors such as each company's financial health, its standing within its industry, and broader market and economic conditions.
FIDGX Mutual Fund Chart & Stats
- Previous Close
- $33.14
- Sub-Category
- Small Cap
- Total Liabilities
- $414.28M
- Last Dividend Ex-Date
- Sep 11, 2026
- Expense Ratio
- 0.79%
- Holding Count
- 305
- Brand
- Fidelity Securities Fund
- Dividend Yield
- (24.00%)
- Category
- Equity
- Total Assets
- 9.21B
- Shares Outstanding
- N/A
- 52-Week Range
- $32.30 - $45.75
FIDGX Mutual Fund News
Spyre Therapeutics Faces Ongoing Dilution Risk and Strategic Constraints From Heavy Reliance on External Financing
Spyre Therapeutics, Inc (SYRE) has disclosed a new risk, in the Share Price & Shareholder Rights category. Spyre Therapeutics, Inc is expected to rely heavily on external financing until its
FIDGX Mutual Fund Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| USD_CASHFidelity Revere Street Trust | 4.31% |
| USD_CASHFidelity Revere Street Trust | 1.70% |
| BTSGBrightSpring Health Services, Inc. | 1.36% |
| ENVAEnova International Inc. | 1.15% |
| COGTCogent Biosciences, Inc. | 1.11% |
| IDCCInterdigital | 1.03% |
| INTAIntapp, Inc. | 1.01% |
| RSIRush Street Interactive, Inc. | 0.87% |
| SYRESpyre Therapeutics, Inc | 0.87% |
| XMTRXometry, Inc. | 0.84% |
| Total | 14.25% |
Recently Viewed
No data currently available





